Breaking News
Get 45% Off 0
Is it finally time to sell Nvidia ahead of earnings?
Read More

LifePoint Health (LPNT) Q4 Earnings Miss On Lower Revenues

By Zacks Investment ResearchStock MarketsFeb 25, 2018 11:27PM ET
www.investing.com/analysis/lifepoint-health-lpnt-q4-earnings-miss-on-lower-revenues-200294283
LifePoint Health (LPNT) Q4 Earnings Miss On Lower Revenues
By Zacks Investment Research   |  Feb 25, 2018 11:27PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
ELV
+0.04%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
UNH
-1.05%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
LPNT
0.00%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
CNC
+2.17%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

LifePoint Health, Inc. (NASDAQ:LPNT) reported earnings of 77 cents per share in fourth-quarter 2017 that missed the Zacks Consensus Estimate by 4.94%. Also, the figure declined 41.5% year over year, due to revenue decline and increase in expenses.

Operational Update

Revenues of $1.49 billion missed the Zacks Consensus Estimate by 5.3% and fell roughly 5.2% year over year.

Provision for doubtful accounts was $282.4 million in the reported quarter, up 22.7% year over year.

LifePoint Health, Inc. Price, Consensus and EPS Surprise

LifePoint Health, Inc. Price, Consensus and EPS Surprise | LifePoint Health, Inc. Quote

Equivalent admissions declined 3% year over year to 172,791 and revenue per equivalent admission was down 4.2% year over year to $8625.

Total expenses of $1.55 billion increased 1.3% year over year.

At the end of the fourth quarter, the company had 71 hospitals compared with 72 hospitals in the year-ago quarter.

Financial Update

As of Dec 31, 2017, the company had total assets of $6.29 billion, down 0.5% year over year.

Cash and cash equivalents totaled $112 million, up 16.5% year over year.

As of Dec 31, 2017, long-term debt declined 0.5% to $2.88 billion from year-end 2016.

Net cash provided by operating activities totaled $178.2 million, up 73.9% year over year.

2018 Guidance

The company expects earnings per share in the range of $4-$4.53, and adjusted EBITDA is expected within $725-$765 million.

Also, LifePoint Health projects revenues within $6.35-$6.43 billion, same hospital revenue growth of 1.4% to 2.7%, and capital expenditures of $475 million to $500 million.

Zacks Rank & Performance of Peers

LifePoint Health presently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Among the other firms in the medical sector that have reported their fourth-quarter earnings so far, the bottom line at Centene Corp. (NYSE:CNC) , Anthem Inc. (NYSE:ANTM) and UnitedHealth Group Inc. (NYSE:UNH) beat their respective Zacks Consensus Estimate.

Will You Make a Fortune on the Shift to Electric Cars?

Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>



UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report

Anthem, Inc. (ANTM): Free Stock Analysis Report

Centene Corporation (CNC): Free Stock Analysis Report

LifePoint Health, Inc. (LPNT): Free Stock Analysis Report

Original post

Zacks Investment Research

LifePoint Health (LPNT) Q4 Earnings Miss On Lower Revenues
 

Related Articles

LifePoint Health (LPNT) Q4 Earnings Miss On Lower Revenues

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email